A site that tries to give only the facts on a subject without all the self serving crap. You may not like what I say, but that's too bad. It's the truth as I see it.
The more important issue hasn't been addressed
Published on April 16, 2005 By spinkiller In Current Events
Either the media has deliberately sidestepped the real issue concerning the release of the 1957 Influenza virus, or just does not get the real impact. The virus was sent out in ID panels to labs around the world, as is done every year. The panels that are sent have a number of unknown viral samples, and the labs getting them are supposed to treat the samples just as if they were collected from an infected patient. The lab is to use at least BSL2, or BSL3 precautions (Bio Safety Level), and as long as the personnel follow procedures, they will be fine. The reporters, and the CDC making a big deal over the fact that no one is sick, are only sidestepping the real issue.
The story should be focused more on how a virus of known pathogenicity got through almost 5,000 labs around the world, and only one lab located in Canada was able to ID the strain?
The short version on the subject of Influenza subtypes is at the beginning of the flu season, the subtype is found through testing. The strain is given an “H” and an “N” designate. This is used to come up with a vaccine for the season, and the testing continues through the season to watch for any changes or mutations of the virus. The usual “H” designates found are 1 and 3, with the two of them found in the annual vaccine.
The “H2” has not been seen in over 30 years, this being the one that was sent. The H2N2 strain from 1957, also known as the Asian flu, caused a pandemic killing around 4 million people.
This all leads up to the point I am trying to make. After the attack on 9/11, our labs across the nation were supposed to be at the highest security for pathogens. The “H2” Influenza virus certainly falls in this category, as it is highly infective, able to be spread at pandemic proportions, and has an incredibly high mortality rate. The Government has said billions of dollars were spent upgrading the labs across the country, yet not a single one, and the sample was sent to somewhere around 4,000 labs in the US alone, were able to ID the “H2” virus. Forget the “N” designate of the virus, just the fact that no lab has seen a “H2” Influenza virus in over 30 years should automatically make all the bells & whistles go off. If a virus that has a mortality and infection rate that rivals most epidemics doesn’t cause someone in the lab to stop and take notice, what will?
Although the idea of using this type of virus for bioterrorism would be slim, the fact that only one lab in the entire world identified it, and it not even being from the United States, makes us wonder just how well those billions of dollars were spent. Things like this should make everyone wonder just how safe we really are.

Comments
on Apr 16, 2005

LW,

No, actually the idea that the lab in Canada just happened to be the first, not the only, never occurred to me.

There are a few reasons for this; the first does not have much credence, as it came from the same media that brought the story in the first place. This being the afore mentioned media stating that the Canadian lab was the only one able to successfully subtype the virus. I have found that as a rule, the media rarely gets any story out to the public with 100% accuracy.

Another reason I find it to be true is the point made during the live feed from the CDC. One of the director’s assured us, the public, that there is no need for concern. When the Canadian lab of the H2N2 find contacted them, all labs across the world were contacted and told to destroy the sample. You can be sure that if any U.S. labs had made a proper ID, the CDC would have made mention of it. This was a major screw up, and a major find for the lab (or labs) that found it. If there was a lab in the states that had come up with a H2 result, we would have been told. I am certain our government did not want to give all the credit to a Canadian firm.

The last reason, but certainly not the least of them, is because the first of the panels were sent out at the beginning of Sept. of last year, and according to the CDC, they were contacted in March of the problem. That gave 5,000 labs six months to ID the samples. As a rule, the labs do not drop everything else when the panels come in, but certainly get started on them within a month. If the last of the labs got their panels in Oct., and they did not start on them for an entire month, all the labs would have had at least four months to ID the samples.

No, it is quite clear that the U.S. labs dropped the ball on this one.
In addition, for the record, I am not the biggest fan of Canada, but kudos to them, and the lab that made the ID.